GFAP is commonly considered a marker for astrogliosis, and other transcripts associated with gliosis [55–57], including CD44, VIM, OSMR, CP, S1PR3, HSPB1, are elevated in the human AD portrait and matching mouse models, suggesting reactive astrocytes could contribute to the profile. Here, CD44 is linked to Alzheimer disease.